Download DNB 2019 Dec 2019 Dec MEDICAL ONCOLOGY PAPER II Question Paper

FirstRanker.com

FINAL EXAM

DECEMBER 2019

--- Content provided by⁠ FirstRanker.com ---

MEDICAL ONCOLOGY

PAPER-II

Time: 3 hours MED.ONCO/D/19/17/11 Max. Marks:100

Important Instructions:

• Attempt all questions in order.

--- Content provided by‍ FirstRanker.com ---

• Each question carries 10 marks.
• Read the question carefully and answer to the point neatly and legibly.
• Do not leave any blank pages between two answers.
• Indicate the question number correctly for the answer in the margin space.
• Answer all the parts of a single question together.

--- Content provided by‌ FirstRanker.com ---

• Start the answer to a question on a fresh page or leave adequate space between two answers.
• Draw table/diagrams/flowcharts wherever appropriate.

Write short notes on:

1. a) What is minimal residual disease (MRD) in acute leukemia? 2+4+4
   b) Various methods of detection, cut off value and limitations of MRD in acute lymphoblastic leukemia.
   

   --- Content provided by​ FirstRanker.com ---

   c) Prognostic and therapeutic implications of MRD in acute lymphoblastic leukemia.
2. a) Solitary pulmonary nodule. 4+3+3
   b) Growing teratoma syndrome.
   c) Port site metastasis.
3. a) Differential diagnosis of pulmonary infiltrates in cancer patients. 3+4+3
   

   --- Content provided by‌ FirstRanker.com ---

   b) Evaluation and management of pulmonary infiltrate in cancer patients.
   c) Describe chemotherapy related pulmonary toxicity.
4. a) Indications of radionuclide bone scan in oncology practice. 3+2+5
   b) What is a superscan?
   c) Management of metastatic bone disease.

--- Content provided by⁠ FirstRanker.com ---

5. a) What are tumour markers? 2+4+4
   b) Describe in detail the role of tumour markers in gynecological malignancies.
   c) Management of rising CA 125 in previously treated case of epithelial ovarian cancer.
6. a) Robotic surgery. 3+4+3
   b) Video assisted thoracic surgery.
   

   --- Content provided by FirstRanker.com ---

   c) Natural orifice transluminal endoscopic surgery (NOTES).
7. a) Management of post chemotherapy residual mass in germ cell tumour. 4+3+3
   b) Types of retroperitoneal lymph node dissection (RPLND).
   c) Long term complications of RPLND.
8. Endoscopic ultrasound. 2+4+4

--- Content provided by⁠ FirstRanker.com ---

9. Role of endobronchial ultrasound in staging of mediastinal nodes in non-small cell lung cancer. 2+4+4
10. a) BI-RADS classifications for mammography. 2+2
    b) Define febrile neutropenia.
    c) How will you evaluate and manage patients with febrile neutropenia in oncology clinical practice? 4+4+2
11. Antibiogram.

--- Content provided by FirstRanker.com ---

12. Pedfilgrastim.
13. WHO classification of primary brain tumours.
14. Prognostic and diagnostic molecular markers in primary brain tumours.
15. Role of Bevacizumab in glioblastoma multiforme.

POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE EXAMINATION HALL.

--- Content provided by‍ FirstRanker.com ---